Contact
searchSearch
HMP Global
Login

After Treatment

After Treatment
Focuses on comprehensive follow-up care, rehabilitation, and monitoring for cancer survivors. This stage, often referred to as Survivorship Care, is crucial to supporting long-term health and managing any lingering side effects.

Trending From ACCC
Delivery of Psychosocial Care in Oncology Summit
08/08/2023
This column summarizes the sessions from the Association of Community Cancer Centers (ACCC) multistakeholder meeting, “A Call to Action: Delivery of Psychosocial Care in Oncology Summit,” which took place on March 8, 2023, in Washington, DC.
This column summarizes the sessions from the Association of Community Cancer Centers (ACCC) multistakeholder meeting, “A Call to Action: Delivery of Psychosocial Care in Oncology Summit,” which took place on March 8, 2023, in Washington, DC.
This column summarizes the...
08/08/2023
Journal of Clinical Pathways
Research Reports
Post–COVID-19 Syndrome Clinical Pathway for the US Veterans Health Administration
02/06/2023
Allison M. Gustavson, DPT, PhD; Johnson Vachachira, NP; Claudia L. Campos, MD; Jacob B. Lindheimer, PhD; Kristina Crothers, MD; Omar Awan, MD; Carrie B. May, PsyD; Cristina Nguyen, BS; Courtney Sedillo, MSN, FNP-C; Francis J. Miller, Jr., MD
Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...
Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...
Lindheimer et al summarize the...
02/06/2023
Journal of Clinical Pathways
Clinical Pathways GPS
Improving Diabetic Management in Long-term Care
02/15/2022
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Richard G Stefanacci, DO, MGH, MBA, and colleagues discuss how clinical pathways can improve the Quadruple Aim for the management of diabetes in long-term care.
Richard G Stefanacci, DO, MGH, MBA, and colleagues discuss how clinical pathways can improve the Quadruple Aim for the management of diabetes in long-term care.
Richard G Stefanacci, DO, MGH,...
02/15/2022
Journal of Clinical Pathways
Clinical Pathways GPS
Clinical Pathways Improving Management of Rare Conditions
08/19/2021
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH,...
08/19/2021
Journal of Clinical Pathways
Research Reports
Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study
05/18/2021
Drishti Shah, PhD; Jason Yeaw, MPH; Amy Kincaid, MA; Paul N. Mudd, Jr., PharmD, MBA; Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.
Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.
Richard Stefanacci, DO, and...
05/18/2021
Journal of Clinical Pathways
Engaging Payers
An Alternative Value-Based Care Model for Chronic Conditions
11/18/2020
Lili Brillstein, MPH
Chronic diseases represent a growing burden of morbidity, mortality, and cost worldwide. Individuals requiring chronic care are most vulnerable to the type of care delivered under the fee-for-service (FFS) model,...
Chronic diseases represent a growing burden of morbidity, mortality, and cost worldwide. Individuals requiring chronic care are most vulnerable to the type of care delivered under the fee-for-service (FFS) model,...
...
11/18/2020
Journal of Clinical Pathways
Research Reports
Trend in TKI Use, Adherence, and Switching Patterns in Patients With CML: Before and After the Availability of Generic Imatinib
08/19/2020
Gary H. Lyman, MD, MPH, FASCO, FRCP, FACP; David R. Doody, MS; Shasank Chennupati, PharmD, MPH; Eric J. Chow, MD, MPH; Lena E. Winestone, MD, MSHP; Henry J. Henk, PhD; Pamela Morin, MBA; Jennifer J. Wilkes, MD, MSCE
Abstract: The therapeutic landscape for chronic myeloid leukemia (CML) has evolved substantially over the past decade, most notably with the introduction of second- and third-generation tyrosine kinase inhibitors...
Abstract: The therapeutic landscape for chronic myeloid leukemia (CML) has evolved substantially over the past decade, most notably with the introduction of second- and third-generation tyrosine kinase inhibitors...
...
08/19/2020
Journal of Clinical Pathways
From the Field
Insights Gained From a Pilot Study Investigating Early Survivorship Care Interventions
06/17/2020
Deborah Christensen, MSN, APRN; Cheryl Bellomo, MSN, RN, OCN; Bonita S. Agee, PhD
Abstract: Intermountain Healthcare, a Utah-based, not-for-profit organization, co-sponsored a pilot study to evaluate potential benefits of early survivorship care by offering a treatment summary and survivorship...
Abstract: Intermountain Healthcare, a Utah-based, not-for-profit organization, co-sponsored a pilot study to evaluate potential benefits of early survivorship care by offering a treatment summary and survivorship...
...
06/17/2020
Journal of Clinical Pathways
Research Reports
Resource Utilization and Expenditures During the “Watchful Waiting” Period in Patients With Recurrent Ovarian Cancer
02/19/2019
Karin Travers, DSc; Adrienne M. Gilligan, PhD; Paula Smith, MS; Paul Juneau, MS; Mohan Bala, PhD; Brian M. Davis, PhD; Brooke Harrow, PhD
Abstract: This article aims to quantify the use of health services during the watchful waiting period after second-line platinum-based therapy among patients with ovarian cancer. Women newly diagnosed with ovarian,...
Abstract: This article aims to quantify the use of health services during the watchful waiting period after second-line platinum-based therapy among patients with ovarian cancer. Women newly diagnosed with ovarian,...
...
02/19/2019
Journal of Clinical Pathways
Research in Review
Lenalidomide Maintenance Prolongs PFS in Older Patients With Diffuse B-Cell Lymphoma
05/12/2017
Lenalidomide maintenance therapy for 24 months after obtaining a complete or partial response to standard chemotherapy significantly prolongs progression-free survival (PFS) in older patients with diffuse large...
Lenalidomide maintenance therapy for 24 months after obtaining a complete or partial response to standard chemotherapy significantly prolongs progression-free survival (PFS) in older patients with diffuse large...
...
05/12/2017
Journal of Clinical Pathways
JCP Nov-Dec Cover

Current Issue

December 2025
Volume 11
Issue 6
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use